Mainz Biomed B.V. Ownership 2024 | Who Owns Mainz Biomed B.V. Now?
Institutional Ownership
0.49%
Insider Ownership
21.63%
Retail Ownership
77.88%
Institutional Holders
9.00
Mainz Biomed B.V. Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORTHERN TRUST CORP | 0.14% | - | 29,934 | - | - | 12,004,000 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.12% | - | 25,000 | - | - | 10,025 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.07% | - | 15,189 | - | - | 6,090 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.05% | 0.00% | 11,358 | -17,418 | -60.53% | 4,555 | Jun 30, 2024 |
| GREENWICH INVESTMENT MANAGEMENT, INC. | 0.05% | 0.00% | 10,859 | -1,125 | -9.39% | 4,355 | Jun 30, 2024 |
| WEALTH QUARTERBACK LLC | 0.05% | 0.00% | 10,000 | 10,000 | 100.00% | 4,010 | Jun 30, 2024 |
| MORGAN STANLEY | 0.00% | - | 200 | -10,047 | -98.05% | 80 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 100 | - | - | 40 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -3,207 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
Mainz Biomed B.V.'s largest institutional shareholder is NORTHERN TRUST CORP, holding 0.14% of the company's total share outstanding, currently valued at $12.00M. The top 10 institutional shareholders own together 0.48% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREENWICH INVESTMENT MANAGEMENT, INC. | 0.05% | 0.00% | 10,859 | -1,125 | -9.39% | 4,355 | Jun 30, 2024 |
| WEALTH QUARTERBACK LLC | 0.05% | 0.00% | 10,000 | 10,000 | 100.00% | 4,010 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.05% | 0.00% | 11,358 | -17,418 | -60.53% | 4,555 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.12% | - | 25,000 | - | - | 10,025 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 29,934 | - | - | 12,004,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.07% | - | 15,189 | - | - | 6,090 | Jun 30, 2024 |
| MORGAN STANLEY | 0.00% | - | 200 | -10,047 | -98.05% | 80 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 100 | - | - | 40 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -3,207 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
The largest Mainz Biomed B.V. shareholder by % of total assets is GREENWICH INVESTMENT MANAGEMENT, INC.. The company owns 10.86K shares of Mainz Biomed B.V. (MYNZ), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WEALTH QUARTERBACK LLC | 0.05% | 0.00% | 10,000 | 10,000 | 100.00% | 4,010 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 100 | - | - | 40 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.07% | - | 15,189 | - | - | 6,090 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 29,934 | - | - | 12,004,000 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.12% | - | 25,000 | - | - | 10,025 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| GREENWICH INVESTMENT MANAGEMENT, INC. | 0.05% | 0.00% | 10,859 | -1,125 | -9.39% | 4,355 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -3,207 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.00% | - | 200 | -10,047 | -98.05% | 80 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.05% | 0.00% | 11,358 | -17,418 | -60.53% | 4,555 | Jun 30, 2024 |
As of Jun 30 2024, Mainz Biomed B.V.'s largest institutional buyer is WEALTH QUARTERBACK LLC. The company purchased 10.00K stocks of MYNZ, valued at $4.01K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| XTX TOPCO LTD | 0.05% | 0.00% | 11,358 | -17,418 | -60.53% | 4,555 | Jun 30, 2024 |
| MORGAN STANLEY | 0.00% | - | 200 | -10,047 | -98.05% | 80 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -3,207 | -100.00% | - | Jun 30, 2024 |
| GREENWICH INVESTMENT MANAGEMENT, INC. | 0.05% | 0.00% | 10,859 | -1,125 | -9.39% | 4,355 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.12% | - | 25,000 | - | - | 10,025 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 29,934 | - | - | 12,004,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.07% | - | 15,189 | - | - | 6,090 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 100 | - | - | 40 | Jun 30, 2024 |
| WEALTH QUARTERBACK LLC | 0.05% | 0.00% | 10,000 | 10,000 | 100.00% | 4,010 | Jun 30, 2024 |
As of Jun 30 2024, Mainz Biomed B.V.'s biggest institutional seller is XTX TOPCO LTD. The company sold -17.42K shares of MYNZ, valued at $4.55K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WEALTH QUARTERBACK LLC | 0.05% | 0.00% | 10,000 | 10,000 | 100.00% | 4,010 | Jun 30, 2024 |
Mainz Biomed B.V.'s largest new institutional shareholder by number of shares is WEALTH QUARTERBACK LLC, purchased 10.00K shares, valued at $4.01K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | - | - | - | -3,207 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
Mainz Biomed B.V.'s largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -3.21K shares, valued at -, as of undefined.
Mainz Biomed B.V. Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -25.00% |
| 31 Mar, 24 | 12 | 9.09% |
| 31 Dec, 23 | 11 | 37.50% |
| 30 Sep, 23 | 8 | -11.11% |
| 30 Jun, 23 | 9 | 50.00% |
| 31 Mar, 23 | 6 | - |
| 31 Dec, 22 | 6 | 50.00% |
| 30 Sep, 22 | 4 | 33.33% |
| 30 Jun, 22 | 3 | -50.00% |
| 31 Mar, 22 | 6 | 200.00% |
| 31 Dec, 21 | 2 | - |
As of 30 Jun 24, 9 institutions are holding Mainz Biomed B.V.'s shares, representing a decrease of -25.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 103,313 | -29.61% |
| 31 Mar, 24 | 146,767 | -36.73% |
| 31 Dec, 23 | 231,967 | 1051.26% |
| 30 Sep, 23 | 20,149 | 5.62% |
| 30 Jun, 23 | 19,077 | -5.26% |
| 31 Mar, 23 | 20,136 | 0.17% |
| 31 Dec, 22 | 20,102 | 28.58% |
| 30 Sep, 22 | 15,634 | -7.16% |
| 30 Jun, 22 | 16,840 | -3.47% |
| 31 Mar, 22 | 17,445 | -14.08% |
| 31 Dec, 21 | 20,303 | - |
Mainz Biomed B.V. (MYNZ) has 103.31K shares outstanding as of 30 Jun 24, down -29.61% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.49% | 59.78% |
| 31 Mar, 24 | 0.90% | 42.82% |
| 31 Dec, 23 | 1.45% | 7960.18% |
| 30 Sep, 23 | 0.14% | 800.69% |
| 30 Jun, 23 | 0.13% | 691.03% |
| 31 Mar, 23 | 0.14% | 679.93% |
| 31 Dec, 22 | 0.14% | 1098.50% |
| 30 Sep, 22 | 0.11% | 758.50% |
| 30 Jun, 22 | 0.12% | 716.83% |
| 31 Mar, 22 | 0.13% | 164.84% |
| 31 Dec, 21 | 0.28% | - |
As of 30 Jun 24, Mainz Biomed B.V. is held by 0.49% institutional shareholders, representing a 59.78% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -75.00% |
| 31 Mar, 24 | 4 | -50.00% |
| 31 Dec, 23 | 8 | 700.00% |
| 30 Sep, 23 | 1 | -66.67% |
| 30 Jun, 23 | 3 | 200.00% |
| 31 Mar, 23 | 1 | -75.00% |
| 31 Dec, 22 | 4 | 100.00% |
| 30 Sep, 22 | 2 | 100.00% |
| 30 Jun, 22 | 1 | -80.00% |
| 31 Mar, 22 | 5 | 150.00% |
| 31 Dec, 21 | 2 | - |
1 institutional shareholders have increased their position in MYNZ stock as of 30 Jun 24 compared to 4 in the previous quarter (a -75.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -25.00% |
| 31 Mar, 24 | 4 | 300.00% |
| 31 Dec, 23 | 1 | -66.67% |
| 30 Sep, 23 | 3 | 50.00% |
| 30 Jun, 23 | 2 | 100.00% |
| 31 Mar, 23 | 1 | - |
| 31 Dec, 22 | 1 | - |
| 30 Sep, 22 | 1 | - |
| 30 Jun, 22 | 1 | - |
| 31 Mar, 22 | 1 | - |
| 31 Dec, 21 | - | - |
3 institutional shareholders have reduced their position in MYNZ stock as of 30 Jun 24 compared to 4 in the previous quarter (a -25.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 9 | -25.00% | 103,313 | -29.61% | 0.49% | 59.78% | 1 | -75.00% | 3 | -25.00% |
| 31 Mar, 24 | 12 | 9.09% | 146,767 | -36.73% | 0.90% | 42.82% | 4 | -50.00% | 4 | 300.00% |
| 31 Dec, 23 | 11 | 37.50% | 231,967 | 1051.26% | 1.45% | 7960.18% | 8 | 700.00% | 1 | -66.67% |
| 30 Sep, 23 | 8 | -11.11% | 20,149 | 5.62% | 0.14% | 800.69% | 1 | -66.67% | 3 | 50.00% |
| 30 Jun, 23 | 9 | 50.00% | 19,077 | -5.26% | 0.13% | 691.03% | 3 | 200.00% | 2 | 100.00% |
| 31 Mar, 23 | 6 | - | 20,136 | 0.17% | 0.14% | 679.93% | 1 | -75.00% | 1 | - |
| 31 Dec, 22 | 6 | 50.00% | 20,102 | 28.58% | 0.14% | 1098.50% | 4 | 100.00% | 1 | - |
| 30 Sep, 22 | 4 | 33.33% | 15,634 | -7.16% | 0.11% | 758.50% | 2 | 100.00% | 1 | - |
| 30 Jun, 22 | 3 | -50.00% | 16,840 | -3.47% | 0.12% | 716.83% | 1 | -80.00% | 1 | - |
| 31 Mar, 22 | 6 | 200.00% | 17,445 | -14.08% | 0.13% | 164.84% | 5 | 150.00% | 1 | - |
| 31 Dec, 21 | 2 | - | 20,303 | - | 0.28% | - | 2 | - | - | - |
Mainz Biomed B.V. Peer Ownership
| Ticker | Company |
|---|---|
| GTH | Genetron Holdings Limited |
| APDN | Applied DNA Sciences, Inc. |
| LAB | Standard BioTools Inc. |
| LMDX | LumiraDx Limited |
| SERA | Sera Prognostics, Inc. |
| BNR | Burning Rock Biotech Limited |
| PRE | Prenetics Global Limited |
| NOTV | Inotiv, Inc. |
| DRIO | DarioHealth Corp. |
| NDRA | ENDRA Life Sciences Inc. |
| OLK | Olink Holding AB (publ) |
| BDSX | Biodesix, Inc. |
| FONR | FONAR Corporation |
| STIM | Neuronetics, Inc. |
| MDXH | MDxHealth SA |
MYNZ Ownership FAQ
Who Owns Mainz Biomed B.V.?
Mainz Biomed B.V. is owned by institutional shareholders (0.49%), insiders (21.63%), and public (77.88%). The largest institutional shareholder of Mainz Biomed B.V. is NORTHERN TRUST CORP (0.14% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of Mainz Biomed B.V.?
Mainz Biomed B.V.'s major institutional shareholders are NORTHERN TRUST CORP, VONTOBEL HOLDING LTD., GEODE CAPITAL MANAGEMENT, LLC, XTX TOPCO LTD, and GREENWICH INVESTMENT MANAGEMENT, INC.. The top five shareholders own together 0.44% of the company's share outstanding.
How many Mainz Biomed B.V. shareholders are there?
As of Jun 2024, there are 9 institutional shareholders of Mainz Biomed B.V..
What percentage of Mainz Biomed B.V. is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP owns 29.93K shares of Mainz Biomed B.V., representing 0.14% of the company's total shares outstanding, valued at $12M (as of Jun 2024).
What percentage of Mainz Biomed B.V. is owned by VONTOBEL HOLDING LTD?
As of Jun 2024, VONTOBEL HOLDING LTD holds 25K shares of Mainz Biomed B.V. (MYNZ), compromising 0.12% of the company, valued at $10.02K.
What percentage of Mainz Biomed B.V. is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Mainz Biomed B.V.. The company owns 15.19K of the company's shares outstanding (worth $6.09K).